Shanghai MicroPort MedBot (Group) Co., Ltd. (HKG:2252)
Hong Kong · Delayed Price · Currency is HKD | Market Cap | 35.21B +91.0% |
| Revenue (ttm) | 613.24M +114.2% |
| Net Income | -277.82M |
| EPS | -0.27 |
| Shares Out | 1.03B |
| PE Ratio | n/a |
| Forward PE | 332.61 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 3,880,491 |
| Average Volume | 7,704,557 |
| Open | 34.50 |
| Previous Close | 34.14 |
| Day's Range | 33.18 - 34.52 |
| 52-Week Range | 14.58 - 34.96 |
| Beta | 1.44 |
| RSI | 72.99 |
| Earnings Date | Mar 26, 2026 |
About HKG:2252
Shanghai MicroPort MedBot (Group) Co., Ltd. engages in the research and development, design, manufacture, and sale of surgical robots in the People’s Republic of China. The company offers Toumai, a laparoscopic surgical robot for use in urologic, gynecologic, thoracic, and general surgeries; DFVision, a 3D electronic laparoscope, which is used in laparoscopic surgeries for abdominal, thoracic, and pelvic organs; SkyWalker, an orthopedic surgical robot for knee arthroplasty and hip arthroplasty; R-One, a vascular interventional surgical robot fo... [Read more]
Financial Performance
In 2025, HKG:2252's revenue was 551.07 million, an increase of 114.22% compared to the previous year's 257.25 million. Losses were -249.66 million, -61.14% less than in 2024.
Financial numbers in CNY Financial StatementsNews
AI surgery: Chinese robot conducts complex operation on pig without human intervention
A robot developed by a Chinese company has successfully performed a biliary surgery on a 30kg pig, using an AI model to perform the procedure autonomously. The experiment, which took place on December...